These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16266820)

  • 41. [Evaluation of the effectiveness of ¹⁸F-FDG-PET/CT examination of head and neck cancer--own experience].
    Majchrzak E; Cholewiński W; Szybiak B; Luczewski L; Sówka M; Golusiński P; Golusiński W
    Otolaryngol Pol; 2013; 67(1):18-24. PubMed ID: 23374659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
    Peters TT; Senft A; Hoekstra OS; Castelijns JA; Witte BI; Leemans CR; de Bree R
    Oral Oncol; 2015 Mar; 51(3):267-71. PubMed ID: 25552384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study.
    Flygare L; Al-Ubaedi A; Öhman W; Mo SJ
    Acta Radiol; 2020 Sep; 61(9):1196-1204. PubMed ID: 31902218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (18)F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma.
    Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Br J Cancer; 2013 Dec; 109(12):2973-9. PubMed ID: 24149172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
    Yankevich U; Hughes MA; Rath TJ; Fakhran S; Alhilahi LM; Seungwon KW; Branstetter BF
    AJR Am J Roentgenol; 2017 Apr; 208(4):844-848. PubMed ID: 28177644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
    Lonneux M; Hamoir M; Reychler H; Maingon P; Duvillard C; Calais G; Bridji B; Digue L; Toubeau M; Grégoire V
    J Clin Oncol; 2010 Mar; 28(7):1190-5. PubMed ID: 20124179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.
    Prestwich RJ; Subesinghe M; Gilbert A; Chowdhury FU; Sen M; Scarsbrook AF
    Clin Radiol; 2012 Oct; 67(10):966-75. PubMed ID: 22595082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
    Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
    Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
    Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
    King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
    Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
    Stadler TM; Morand GB; Rupp NJ; Hüllner MW; Broglie MA
    Head Neck; 2021 Jul; 43(7):2058-2068. PubMed ID: 33729625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL
    Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
    Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
    Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis.
    Xu GZ; Guan DJ; He ZY
    Oral Oncol; 2011 Jul; 47(7):560-5. PubMed ID: 21621450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The value of PET-CT imaging in malignant tumours of the head and neck].
    Balink H; Krabbe CA; de Visscher JG
    Ned Tijdschr Geneeskd; 2007 May; 151(21):1167-72. PubMed ID: 17557755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer.
    Arias F; Chicata V; García-Velloso MJ; Asín G; Uzcanga M; Eito C; Quilez I; Viudez A; Saenz J; Hernández I; Caicedo C; Errasti M; Barrado M; García-Bragado F
    Clin Transl Oncol; 2015 Feb; 17(2):139-44. PubMed ID: 25078571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Role of [18]-FDG PET/CT in the initial staging of head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Mundler O; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):3-9. PubMed ID: 17633658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.